Guggenheim Capital LLC Takes $359,000 Position in Doximity, Inc. (NASDAQ:DOCS)

Guggenheim Capital LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 6,731 shares of the company's stock, valued at approximately $359,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in shares of Doximity by 4.5% in the fourth quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after purchasing an additional 485,102 shares in the last quarter. FMR LLC grew its holdings in Doximity by 37.6% during the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after buying an additional 2,571,580 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Doximity by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock valued at $157,668,000 after buying an additional 95,458 shares during the period. Loomis Sayles & Co. L P lifted its holdings in shares of Doximity by 2.7% in the fourth quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock worth $124,644,000 after buying an additional 62,366 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Doximity by 9.8% in the fourth quarter. Renaissance Technologies LLC now owns 1,847,702 shares of the company's stock valued at $98,649,000 after acquiring an additional 164,200 shares during the period. Institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

DOCS traded up $1.12 on Friday, hitting $59.19. 459,706 shares of the company were exchanged, compared to its average volume of 1,990,476. The firm has a fifty day simple moving average of $59.36 and a two-hundred day simple moving average of $56.50. The stock has a market capitalization of $11.05 billion, a PE ratio of 59.18, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Analysts Set New Price Targets

Several research firms have issued reports on DOCS. Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and increased their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Raymond James restated an "outperform" rating and set a $83.00 target price (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Truist Financial lowered their price target on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a report on Thursday, April 10th. Finally, Mizuho upped their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $65.39.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.